Noncoding RNA therapeutics—challenges and potential solutions
Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …
Classical and noncanonical functions of miRNAs in cancers
Alterations in microRNAs (miRNAs) expression are causative in the initiation and
progression of human cancers. The molecular events responsible for the widespread …
progression of human cancers. The molecular events responsible for the widespread …
The miRNA: a small but powerful RNA for COVID-19
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is a severe and rapidly evolving epidemic. Now …
syndrome coronavirus 2 (SARS-CoV-2) is a severe and rapidly evolving epidemic. Now …
Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain
SARS-CoV-2 is a novel coronavirus that infects cells through the angiotensin-converting
enzyme 2 receptor, aided by proteases that prime the spike protein of the virus to enhance …
enzyme 2 receptor, aided by proteases that prime the spike protein of the virus to enhance …
Neuroinflammation and Its Impact on the Pathogenesis of COVID-19
MM Almutairi, F Sivandzade, TH Albekairi… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …
miRNAs; a novel strategy for the treatment of COVID‐19
H Ying, M Ebrahimi, M Keivan… - Cell biology …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …
MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19
C Hum, J Loiselle, N Ahmed, TA Shaw, C Toudic… - Drugs, 2021 - Springer
Coronaviruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
responsible for the coronavirus disease 2019 (COVID-19) pandemic, present a significant …
responsible for the coronavirus disease 2019 (COVID-19) pandemic, present a significant …
The role of miRNAs in COVID-19 disease
Nowadays, the SARS Coronavirus 2 (SARS-CoV-2) infection is recognized as the primary
cause of mortality in humans. SARS-CoV-2 is transmitted through human-to-human contact …
cause of mortality in humans. SARS-CoV-2 is transmitted through human-to-human contact …
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
S Paul, LAB Vázquez, PR Reyes-Pérez… - Virus Research, 2022 - Elsevier
Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
RNA–RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection
Some studies reported that genomic RNA of SARS-CoV-2 can absorb a few host miRNAs
that regulate immune-related genes and then deprive their function. In this perspective, we …
that regulate immune-related genes and then deprive their function. In this perspective, we …